Literature DB >> 8785313

Tissue average binding and equilibrium distribution: an example with heparin in arterial tissues.

M A Lovich1, E R Edelman.   

Abstract

Classical pharmacokinetic descriptions do not adequately predict the dynamic and complex drug deposition patterns that follow some novel delivery techniques, in part because they do not characterize binding within intact tissues in sufficient detail. In this study, the binding site density of all the potential sites, the tissue-average dissociation constant, and the fractional volume in which heparin can distribute in arterial tissues were measured by incubating tissue samples to equilibrium in solutions containing a wide range of drug concentrations. An "equilibrium distribution curve" was constructed by plotting the concentration of drug in each sample against the concentration in the corresponding bulk phase. The above constants were determined by computationally fitting this curve to a model of drug distribution within tissues. The binding site density was measured to be 4.2 microM, 2.5 microM and 2.2 nM in porcine carotid media with intact and denuded endothelium, and adventitia, respectively. The dissociation constant of heparin in these tissues was estimated to be 6.8 microM, 5.0 microM, and 8.1 nM, respectively. The fractional tissue volume of distribution was 0.61, 0.70, and 0.87, respectively. These values are consistent with known properties of the heparin-arterial tissue interaction. Thus, this technique describes the cumulative effects of binding of a compound to all of its potential binding sites, and will be essential to new detailed descriptions of drug distribution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785313      PMCID: PMC1225083          DOI: 10.1016/S0006-3495(96)79719-9

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  23 in total

1.  Affinity of binding of radiolabeled (125I) heparin and low molecular weight heparin fraction CY 222 to endothelium in culture.

Authors:  P Psuja
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1987

2.  Collagen types in various layers of the human aorta and their changes with the atherosclerotic process.

Authors:  K Murata; T Motayama; C Kotake
Journal:  Atherosclerosis       Date:  1986-06       Impact factor: 5.162

3.  Binding of heparin on the surface of cultured human endothelial cells.

Authors:  B Glimelius; C Busch; M Höök
Journal:  Thromb Res       Date:  1978-05       Impact factor: 3.944

4.  Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery.

Authors:  M A Lovich; E R Edelman
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

5.  Binding and endocytosis of heparin by human endothelial cells in culture.

Authors:  T Bârzu; P Molho; G Tobelem; M Petitou; J Caen
Journal:  Biochim Biophys Acta       Date:  1985-05-30

6.  Effect of heparin on vascular smooth muscle cells. I. Cell metabolism.

Authors:  J J Castellot; D L Cochran; M J Karnovsky
Journal:  J Cell Physiol       Date:  1985-07       Impact factor: 6.384

7.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

Authors:  A W Clowes; M A Reidy; M M Clowes
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

8.  Internalization and metabolism of endogenous heparin by cultured endothelial cells.

Authors:  S Vannucchi; F Pasquali; V Chiarugi; M Ruggiero
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

9.  Binding and internalization of heparin by vascular smooth muscle cells.

Authors:  J J Castellot; K Wong; B Herman; R L Hoover; D F Albertini; T C Wright; B L Caleb; M J Karnovsky
Journal:  J Cell Physiol       Date:  1985-07       Impact factor: 6.384

10.  Endothelial binding sites for heparin. Specificity and role in heparin neutralization.

Authors:  T Bârzu; J L Van Rijn; M Petitou; P Molho; G Tobelem; J P Caen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

View more
  9 in total

1.  Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo.

Authors:  M A Lovich; E R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel.

Authors:  Andrew D Levin; Neda Vukmirovic; Chao-Wei Hwang; Elazer R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

3.  Stent elution rate determines drug deposition and receptor-mediated effects.

Authors:  Abraham R Tzafriri; Adam Groothuis; G Sylvester Price; Elazer R Edelman
Journal:  J Control Release       Date:  2012-05-26       Impact factor: 9.776

Review 4.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

5.  Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.

Authors:  Xiaodong Ma; Shizu Oyamada; Fan Gao; Tim Wu; Michael P Robich; Hao Wu; Xingwei Wang; Bryan Buchholz; Stephen McCarthy; Zhiyong Gu; Cesario F Bianchi; Frank W Sellke; Roger Laham
Journal:  J Pharm Biomed Anal       Date:  2010-11-10       Impact factor: 3.935

6.  Myocardial drug distribution generated from local epicardial application: potential impact of cardiac capillary perfusion in a swine model using epinephrine.

Authors:  Mikhail Y Maslov; Elazer R Edelman; Matthew J Pezone; Abraham E Wei; Matthew G Wakim; Michael R Murray; Hisashi Tsukada; Iraklis S Gerogiannis; Adam Groothuis; Mark A Lovich
Journal:  J Control Release       Date:  2014-09-16       Impact factor: 9.776

7.  Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.

Authors:  Abraham R Tzafriri; Sahil A Parikh; Elazer R Edelman
Journal:  J Control Release       Date:  2019-08-17       Impact factor: 9.776

8.  Structural biomechanics modulate intramuscular distribution of locally delivered drugs.

Authors:  Peter I-Kung Wu; Elazer R Edelman
Journal:  J Biomech       Date:  2008-08-15       Impact factor: 2.712

9.  Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery.

Authors:  A R Tzafriri; A D Levin; E R Edelman
Journal:  Cell Prolif       Date:  2009-03-31       Impact factor: 6.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.